Menopause is increasingly recognized as a neurologic transition that may contribute to cognitive decline, heightened Alzheimer disease (AD) risk, and worsening outcomes in multiple sclerosis (MS).1-3 Growing evidence of these associations underscores the need for greater awareness and continued research into the neurologic effects of menopause and the potential role of neuroprotective interventions.
-
Only registered and activated users can see links., Click Here To Register...Yet inside there is this perpetual nagging doubt;
the feeling we are possessed by a 'subtle lack of togetherness''. -
It's good that more attention is being given to this. Women with MS outnumber men with MS by a considerable margin. Thank you for finding and posting this.SPMS diagnosed 1980. Avonex 2001-2004. Copaxone 2006-2009. Glatopa (glatiramer acetate = Copaxone) 12/20 - 3/19/24.
Comment